Effects of cardiac denervation on development of heart failure and catecholamine desensitization

Circulation

Volumn 95, Issue 8, 1997, Pages 2130-2140

  Sato, Naoki ^a   Vatner, Stephen F ^a,b,c,d   Shen, You Tang ^a   Kudej, Raymond K ^a,b,c   Ghaleh Marzban, Bijan ^a   Uechi, Masami ^a   Asai, Kuniya ^a,b   Mirsky, Israel ^a   Patrick, Thomas A ^a,b   Shannon, Richard P ^b   Vatner, Dorothy E ^a,c,d,e  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c Department of Medicine ^*  (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

catecholamines; heart failure; physiology; receptors, beta, adrenergic; ventricular denervation

Indexed keywords

BETA ADRENERGIC RECEPTOR; CATECHOLAMINE; ISOPRENALINE; NORADRENALIN;

ADOLESCENT; ADRENERGIC STIMULATION; ANIMAL MODEL; ARTICLE; CHRONOTROPISM; CONTROLLED STUDY; DOG; FEMALE; HEART DENERVATION; HEART FAILURE; HEMODYNAMICS; INOTROPISM; MALE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR SENSITIVITY;

EID: 0030935560     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.95.8.2130     Document Type: Article

References (36)

1. Raab W. Adrenocortical compounds in the blood: relation of their quantity to arterial hypertension, renal insufficiency and congestive heart failure. Arch Intern Med. 1941;68:713-739.
2. Levine TB, Francis GS, Goldsmith SR, Simon AB, Cohn JN. Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. Am J Cardiol. 1982;49:1659-1666.
3. Leimbach WN, Wallin BG, Victor RG, Aylward PE, Sundlöf G, Mark AL. Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. Circulation. 1986;73:913-919.
4. Thomas JA, Marks BH. Plasma norepinephrine in congestive heart failure. Am J Cardiol. 1978;41:233-243.
5. Riegger AJG, Liebau G. The renin-angiotensin-aldosterone system, antidiuretic hormone and sympathetic nerve activity in an experimental model of congestive heart failure in the dog. Clin Sci. 1982;62:465-469.
6. Chidsey CA, Harrison DC, Braunwald E. Augmentation of plasma norepinephrine response to exercise in patients with congestive heart failure. N Engl J Med. 1962;267:650-654.
7. Gaffney TE, Braunwald E. Importance of adrenergic nervous system in support of circulatory function in patients with congestive heart failure. Am J Med. 1963;34:320-324.
8. Engelmeier RS, O'Connell JB, Walsh R, Rad N, Scanlon PJ, Gunnar RM. Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial. Circulation. 1985;72:536-546.
9. Waagstein F, Bristow MR, Swedberg K, Camerini F, Fowler MB, Silver MA, Gilbert EM, Johnson MR, Goss FG, Hjalmarson Å, for the Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet. 1993;342:1441-1446.
10. Krum H, Sackner-Bernstein JD, Goldsmith RL, Kukin ML, Schwartz B, Penn J, Medina N, Yushak M, Horn E, Katz SD, Levin HR, Neuberg GW, DeLong G, Packer M. Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure. Circulation. 1995;92:1499-1506.
11. Metra M, Nardi M, Giubbini R, Cas LD. Effects of short- and long-term carvedilol administration on rest and exercise hemodynamics variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 1994;24:1678-1687.
12. Tsutsui H, Spinale FG, Nagatsu M, Schmid PG, Ishihara K, DeFreyte G, Cooper G IV, Carabello BA. Effects of chronic β-adrenergic blockade on the left ventricular and cardiocyte abnormalities of chronic canine mitral regurgitation. J Clin Invest. 1994; 93:2639-2648.
13. Warner AL, Bellah KL, Raya TE, Roeske WR, Goldman S. Effects of β-adrenergic blockade of papillary muscle function and the β-adrenergic receptor system in noninfarcted myocardium in compensated ischemic left ventricular dysfunction. Circulation. 1992;86: 1584-1595.
14. Fowler MB, Laser JA, Hopkins GL, Minobe W, Bristow MR. Assessment of the β-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response. Circulation. 1986;74:1290-1302.
15. Colucci WS, Denniss AR, Leatherman GF, Quigg RJ, Ludmer PL, Marsh JD, Gauthier DF. Intracoronary infusion of dobutamine to patients with and without severe congestive heart failure. J Clin Invest. 1988;81:1103-1110.
16. Marzo KP, Frey MJ, Wilson JR, Liang BT, Manning DR, Lanoce V, Molinoff PB. β-Adrenergic receptor-G protein-adenylate cyclase complex in experimental canine congestive heart failure produced by rapid ventricular pacing. Circ Res. 1991;69:1546-1556.
17. Roth DA, Urasawa K. Helmer GA, Hammond HK. Downregulation of cardiac guanosine 5′-triphosphate-binding proteins in right atrium and left ventricle in pacing-induced congestive heart failure. J Clin Invest. 1993;91:939-949.
18. Colucci WS, Riberio JP, Rocco MB, Quigg RJ, Creager MA, Marsh JD, Gauthier DF, Hartley LH. Impaired chronotropic response to exercise in patients with congestive heart failure. Circulation. 1989; 80:314-323.
19. Parker JD, Landzberg JS, Bittl JA, Mirsky I, Colucci WS. Effects of β-adrenergic stimulation with dobutamine on isovolumic relaxation in the normal and failing human left ventricle. Circulation. 1991;84: 1040-1048.
20. Kiuchi K, Shannon RP, Komamura K, Cohen DJ, Bianchi C, Homcy CJ, Vatner SF. Vatner DE. Myocardial β-adrenergic receptor function during the development of pacing induced heart failure. J Clin Invest. 1993;91:907-914.
21. Bristow MR, Ginsberg R, Minobe M, Cubicciotti RS, Sageman WS, Lurie K, Billingham ME, Harrison DC, Stinson EB. Decreased catecholamine sensitivity and β-adrenergic-receptor density in failing human hearts. N Engl J Med. 1982;307:205-211.
22. Liang C-S, Frantz RP, Suematsu M, Sakamoto S, Sullebarger JT, Fan T-HM, Guthinger L. Chronic β-adrenoceptor blockade prevents the development of β-adrenergic subsensitivity in experimental right-sided congestive heart failure in dogs. Circulation. 1991;84:245-266.
23. Harding SE, Poole-Wilson PA. Beta-adrenoceptors in heart failure: a mechanism or a cAMP follower? In: Lewis BS, Kimchi A, eds. Heart Failure Mechanisms and Management. Berlin, Germany: Springer-Verlag; 1991:15-20.
24. Sackner-Bernstein JD, Mancini DM. Rationale for treatment of patients with chronic heart failure with adrenergic blockade. JAMA. 1995;274:1462-1467.
25. Randall WC, Thomas JX Jr, Barber MJ, Rinkema LE. Selective denervation of the heart. Am J Physiol. 1983;244 (Heart Circ Physiol 13):H607-H613.
26. Randall WC, Thomas JX Jr, Barber MJ, Rinkema LE. Selective denervation of the heart. Am J Physiol. 1983;244 (Heart Circ Physiol 13):H607-H613.
27. Levett JM, Marinelli CC, Lund DD, Pardini BJ, Nader S, Scott BD, Augelli NV, Kerber RE, Schmid PG Jr. Effects of β-blockade on neurohormonal responses and neurochemical markers in pacing-induced heart failure. Am J Physiol. 1994;266 (Heart Circ Physiol 35):H468-H475.
28. Levett JM, Marinelli CC, Lund DD, Pardini BJ, Nader S, Scott BD, Augelli NV, Kerber RE, Schmid PG Jr. Effects of β-blockade on neurohormonal responses and neurochemical markers in pacing- induced heart failure. Am J Physiol. 1994;266 (Heart Circ Physiol 35):H468-H475.
29. Vatner DE, Lavallee M, Amano J, Finizola A, Homcy CJ, Vatner SF. Mechanisms of supersensitivity to sympathomimetic amines in the chronically denervated heart of the conscious dog. Circ Res. 1985;57:55-64.
30. Delehanty JM, Himura Y, Elam H, Hood WB, Liang C-S. β-Adrenoceptor downregulation in pacing-induced heart failure is associated with increased interstitial NE content. Am J Physiol. l994;266 (Heart Circ Physiol 35):H930-H935.
31. Delehanty JM, Himura Y, Elam H, Hood WB, Liang C-S. β-Adrenoceptor downregulation in pacing-induced heart failure is associated with increased interstitial NE content. Am J Physiol. l994;266 (Heart Circ Physiol 35):H930-H935.
32. Young MA, Hintze TH, Vatner SF. Correlation between cardiac performance and plasma catecholamine levels in conscious dogs. Am J Physiol. 1985;248 (Heart Circ Physiol 17):H82-H88.
33. Young MA, Hintze TH, Vatner SF. Correlation between cardiac performance and plasma catecholamine levels in conscious dogs. Am J Physiol. 1985;248 (Heart Circ Physiol 17):H82-H88.
34. Vatner DE, Sato N, Kiuchi K, Shannon RP, Vatner SF. Decrease in myocardial ryanodine receptors and altered excitation-contraction coupling early in the development of heart failure. Circulation. 1994;90:1423-1430.
35. sα overexpression. Circ Res. 1996;78:517-524.
36. sα overexpression. Am J Physiol. 1997;272:H585-H589.